These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetics and pharmacogenomics: development, science, and translation. Weinshilboum RM; Wang L Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: a systems approach. Wang L Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):3-22. PubMed ID: 20836007 [TBL] [Abstract][Full Text] [Related]
4. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Hoehe MR; Timmermann B; Lehrach H Curr Pharm Biotechnol; 2003 Dec; 4(6):351-78. PubMed ID: 14683431 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics: historical perspective and current status. Charlab R; Zhang L Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic discovery approaches: will the real genes please stand up? Walgren RA; Meucci MA; McLeod HL J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics, pharmacogenomics and airway disease. Hall IP Respir Res; 2002; 3(1):10. PubMed ID: 11806845 [TBL] [Abstract][Full Text] [Related]
9. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. O'Donnell PH; Bush A; Spitz J; Danahey K; Saner D; Das S; Cox NJ; Ratain MJ Clin Pharmacol Ther; 2012 Oct; 92(4):446-9. PubMed ID: 22929923 [TBL] [Abstract][Full Text] [Related]
12. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity. Chan SL; Jin S; Loh M; Brunham LR Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008 [TBL] [Abstract][Full Text] [Related]
13. No pain relief from codeine...? An introduction to pharmacogenomics. Fagerlund TH; Braaten O Acta Anaesthesiol Scand; 2001 Feb; 45(2):140-9. PubMed ID: 11167158 [TBL] [Abstract][Full Text] [Related]
14. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group. Srinivasan BS; Chen J; Cheng C; Conti D; Duan S; Fridley BL; Gu X; Haines JL; Jorgenson E; Kraja A; Lasky-Su J; Li L; Rodin A; Wang D; Province M; Ritchie MD Pharmacogenomics; 2009 Feb; 10(2):243-51. PubMed ID: 19207025 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect. Sadee W Pharmacogenomics; 2011 May; 12(5):675-80. PubMed ID: 21619429 [TBL] [Abstract][Full Text] [Related]
17. Relating human genetic variation to variation in drug responses. Madian AG; Wheeler HE; Jones RB; Dolan ME Trends Genet; 2012 Oct; 28(10):487-95. PubMed ID: 22840197 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics discovery and implementation in genome-wide association studies era. Ni X; Zhang W; Huang RS Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):1-9. PubMed ID: 23188748 [TBL] [Abstract][Full Text] [Related]
19. Human pharmacogenomic variations and their implications for antifungal efficacy. Meletiadis J; Chanock S; Walsh TJ Clin Microbiol Rev; 2006 Oct; 19(4):763-87. PubMed ID: 17041143 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice. Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]